(Q44786836)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18335000%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

editorial

0 references

title

Mesenchymal stem cells for graft-versus-host disease: a double edged sword? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18335000%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

main subject

mesenchymal stem cell

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18335000%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Francesco Dazzi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18335000%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

F Vianello

series ordinal

1

1 reference

6 December 2017

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18335000%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18335000%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18335000%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18335000%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

463-465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18335000%20AND%20SRC:MED&resulttype=core&format=json

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Interferon-beta mediates stromal cell rescue of T cells from apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Osteoblastic cells regulate the haematopoietic stem cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Minor H antigens: genes and peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

The stem-cell niche as an entity of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Breast-Cancer Stromal Cells withTP53Mutations and Nodal Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatc

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Potential of mesenchymal stem cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Human articular chondrocytes suppress in vitro proliferation of anti-CD3 activated peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.25

7 January 2021